numares AG

numares is a fast-growing innovative diagnostics company that develops and markets software-based test systems for high throughput use in clinical diagnostics and life science research.

The AXINON® System and its individual diagnostic tests employ nuclear magnetic resonance (NMR) spectroscopy creating a “numaric” spectrum to evaluate metabolic networks. The output from these analyses provides physicians valuable information on the disease status of patients.

numares developed its proprietary Magnetic Group Signaling (MGS®) technology to enable NMR for highly standardized and rapid throughput testing, forming a cost-effective new solution for real-time diagnostic purposes. The metabolic tests have the potential to address unmet medical needs in various field such as cardiovascular diseases, nephrology, oncology and neurology, shaping an important pillar in precision medicine.

More information can be found at www.numares.com.

For further information please contact:
numares AG
Dipl.-Biol. Christiane Proll, MBA
Tel.: +49 941 2809 49-14
E-Mail: [email protected]